(Q53136705)

11 May 2018

title

Risk models predicting survival after reduced-intensity transplantation for myelofibrosis. (English)

1 reference

11 May 2018

12

Ulrike Bacher

1 reference

11 May 2018

6

Martin Bornhäuser

1 reference

11 May 2018

11

Francis Ayuk

1 reference

11 May 2018

author name string

Haefaa Alchalby

1

1 reference

11 May 2018

Dinah-Rohina Yunus

2

1 reference

11 May 2018

Tatjana Zabelina

3

1 reference

11 May 2018

Guido Kobbe

4

1 reference

11 May 2018

Ernst Holler

5

1 reference

11 May 2018

Rainer Schwerdtfeger

7

1 reference

11 May 2018

Wolfgang Bethge

8

1 reference

11 May 2018

Hans Michael Kvasnicka

9

1 reference

11 May 2018

Guntram Büsche

10

1 reference

11 May 2018

Axel R Zander

13

1 reference

11 May 2018

Nicolaus Kröger

14

1 reference

11 May 2018

language of work or name

English

0 references

publication date

27 January 2012

1 reference

11 May 2018

British Journal of Haematology

published in

1 reference

11 May 2018

volume

157

1 reference

11 May 2018

issue

1

1 reference

11 May 2018

page(s)

75-85

1 reference

11 May 2018

Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09009.X

Outcome of transplantation for myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09009.X

Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09009.X

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09009.X

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09009.X

Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09009.X

International Prognostic Scoring System-independent cytogenetic risk categorization in primary myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09009.X

Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09009.X

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09009.X

Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09009.X

Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09009.X

Dynamic model for predicting death within 12 months in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09009.X

Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09009.X

Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09009.X

10.1111/J.1365-2141.2011.09009.X

21 January 2018

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018